- 4.8Impact Factor
- 9.2CiteScore
- 20 daysTime to First Decision
Pathogenesis and Targeted Therapy of Neurodegenerative Diseases
This special issue belongs to the section “Molecular Medicine“.
Special Issue Information
Dear Colleagues,
Neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS), represent a growing global health concern due to their increasing prevalence and lack of curative treatments. These disorders are characterized by a progressive loss of neurons and synaptic function, leading to debilitating cognitive and motor impairments. Recent advances in molecular neuroscience have uncovered critical mechanisms underlying disease pathogenesis, including protein misfolding, mitochondrial dysfunction, oxidative stress, and neuroinflammation. Understanding these pathways opens the door to the development of targeted therapies that aim not only to alleviate symptoms but also to modify disease progression. This Special Issue invites original research articles, reviews, and perspectives that explore the molecular mechanisms of neurodegeneration and innovative therapeutic strategies. Contributions highlighting novel biomarkers, emerging therapeutic targets, or translational approaches are particularly encouraged.
Dr. Wioletta Rozpędek-Kamińska
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurodegeneration
- neurodegenerative diseases
- targeted therapy
- molecular mechanisms
- disease-modifying treatments
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

